+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Statins and the risk of new-onset diabetes: a review of recent evidence

Statins and the risk of new-onset diabetes: a review of recent evidence

Current Opinion in Lipidology 22(6): 460-466

Statins are the most prescribed medications worldwide with a proven ability to reduce major cardiovascular events. Recent data have revealed that statin therapy is associated with an increased risk for developing diabetes. We discuss the relevant data including newly published results, which demonstrate a dose-dependent association, we place these findings in clinical context and we consider clinical implications. A recent meta-analysis of most major placebo and standard care-controlled statin trials with more than 90,000 participants confirmed that statin therapy was associated with a 9% increased risk of developing diabetes. Newly published data have confirmed a dose-dependent effect, with 12% higher risk of developing diabetes on intensive-dose statin therapy compared with moderate-dose therapy. In this meta-analysis, one additional patient developed diabetes for every three patients protected from a major cardiovascular event. The observation of higher diabetes risk remains unexplained at present, although studies in animal models suggest the possibility of impaired peripheral insulin signalling induced by statin therapy. The cardiovascular benefits of statin therapy clearly outweigh the risk of developing diabetes. However, the data suggest the need to make patients aware of this possible risk and to monitor patients for development of diabetes, especially on intensive-dose therapy.

(PDF emailed within 0-6 h: $19.90)

Accession: 055911892

Download citation: RISBibTeXText

PMID: 21897230

DOI: 10.1097/MOL.0b013e32834b4994

Related references

Use of antidepressants and statins and short-term risk of new-onset diabetes among high risk adults. Diabetes Research and Clinical Practice 105(2): 251-260, 2014

Statins and risk of new-onset diabetes mellitus. Circulation 126(18): E282-E284, 2013

Research progress on statins use and the risk of new onset diabetes. Zhonghua Xin Xue Guan Bing Za Zhi 44(5): 456-457, 2016

Is the risk of new-onset diabetes by statins associated with diet adherence?. International Journal of Cardiology 166(1): 277-277, 2014

Letter by Koh regarding article, "Statins and risk of new-onset diabetes mellitus". Circulation 127(23): E837-E837, 2013

Does coenzyme Q10 play a role in the risk of new-onset diabetes due to statins?. International Journal of Cardiology 225: 260-261, 2016

Comparison of lower limb kinetics, kinematics and muscle activation during drop jumping under shod and barefoot conditions. Journal of Biomechanics, 2018

Statins and new-onset diabetes mellitus - a risk lacking in familial hypercholesterolaemia. Journal of Internal Medicine 279(4): 358-361, 2016

Statins and risk of new-onset diabetes mellitus: is there a rationale for individualized statin therapy?. American Journal of Cardiovascular Drugs 14(2): 79-87, 2014

Could changes in adiponectin drive the effect of statins on the risk of new-onset diabetes? The case of pitavastatin. Atherosclerosis. Supplements 16: 1-27, 2015

Statins and risk for new-onset diabetes mellitus: A real-world cohort study using a clinical research database. Medicine 95(46): E5429-E5429, 2016

Review of recent evidence in support of a role for statins in the prevention of prostate cancer. Current Opinion in Urology 18(3): 333-339, 2008

Statins and the risk of diabetes: evidence from a large population-based cohort study. Diabetes Care 37(8): 2225-2232, 2015

Impact of statins on risk of new onset diabetes mellitus: a population-based cohort study using the Korean National Health Insurance claims database. Therapeutics and Clinical Risk Management 12(): 1533-1543, 2016

The use of statins in people at risk of developing diabetes mellitus: evidence and guidance for clinical practice. Atherosclerosis. Supplements 15(1): 1-15, 2015